Status: Recruiting
Patient-Derived Xenografts to Reduce Cancer Health Disparities
This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.
Participants needed: 500
Trial details
Age: 21-100Biological sex: AllType: ObservationalSponsor: University of California, DavisUpdated: Aug 20, 2026Locations: 2
Eligibility criteria
Patient receiving treatment for the above 4 cancers (bladder cancer, lung cancer... [+1]
No informed consent obtained [+5]